[go: up one dir, main page]

TR200003521T2 - Re-combined human interferon beta-1a (IFN-beta-1a) formulation. - Google Patents

Re-combined human interferon beta-1a (IFN-beta-1a) formulation.

Info

Publication number
TR200003521T2
TR200003521T2 TR2000/03521T TR200003521T TR200003521T2 TR 200003521 T2 TR200003521 T2 TR 200003521T2 TR 2000/03521 T TR2000/03521 T TR 2000/03521T TR 200003521 T TR200003521 T TR 200003521T TR 200003521 T2 TR200003521 T2 TR 200003521T2
Authority
TR
Turkey
Prior art keywords
beta
ifn
formulation
human interferon
combined human
Prior art date
Application number
TR2000/03521T
Other languages
Turkish (tr)
Inventor
Alam John
Rogge Mark
Goelz Susan
Original Assignee
Biogen, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc filed Critical Biogen, Inc
Publication of TR200003521T2 publication Critical patent/TR200003521T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Bulus, yaklasik pH 7.2 degerinde tampon, yeniden-kombine-edilen interferon-beta ve 15 mg/ml insan serum albumini içeren sivi bilesimleri ve sözü geçen bilesimlerin parenteral kullanimi için kullanma takimlarini saglamaktadir.The invention provides liquid compositions containing buffer at about pH 7.2, recombinant interferon-beta and 15 mg / ml human serum albumin, and use kits for parenteral use of said compounds.

TR2000/03521T 1998-05-29 1998-05-29 Re-combined human interferon beta-1a (IFN-beta-1a) formulation. TR200003521T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/007242 WO1999062542A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (1)

Publication Number Publication Date
TR200003521T2 true TR200003521T2 (en) 2001-07-23

Family

ID=22266817

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03521T TR200003521T2 (en) 1998-05-29 1998-05-29 Re-combined human interferon beta-1a (IFN-beta-1a) formulation.

Country Status (16)

Country Link
EP (1) EP1082132A1 (en)
JP (1) JP2002516874A (en)
KR (1) KR20010052454A (en)
CN (1) CN1299285A (en)
AU (1) AU8822598A (en)
BR (1) BR9815966A (en)
CA (1) CA2333063A1 (en)
EA (1) EA200001252A1 (en)
EE (1) EE200000694A (en)
HU (1) HUP0102241A2 (en)
IL (1) IL139933A0 (en)
IS (1) IS5732A (en)
NO (1) NO20006022L (en)
SK (1) SK17762000A3 (en)
TR (1) TR200003521T2 (en)
WO (1) WO1999062542A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
DE60130145T2 (en) * 2000-12-21 2008-05-15 Resuscitation Technologies, LLC, Santa Monica STABLE T3 COMPOSITIONS AND ITS APPLICATION
CN1325651C (en) * 2001-05-24 2007-07-11 大连金威基因技术有限公司 High-efficiency expression and application of human recombinant interferon B
CN1535724B (en) * 2003-04-23 2012-09-05 北京金迪克生物技术研究所 New application of recombinant human interferon for preventing serious acute respiratory tract syndrome
LT2868315T (en) * 2007-12-04 2017-09-25 Biogen Chesapeake Llc Improved formulations and methods for lyophilization and lyophilates provided thereby
JP2023540800A (en) * 2020-09-12 2023-09-26 アカデミア シニカ Refolded human serum albumin and its antitumor use

Also Published As

Publication number Publication date
IS5732A (en) 2000-11-24
NO20006022D0 (en) 2000-11-28
IL139933A0 (en) 2002-02-10
CA2333063A1 (en) 1999-12-09
AU8822598A (en) 1999-12-20
WO1999062542A1 (en) 1999-12-09
HUP0102241A2 (en) 2001-10-28
EA200001252A1 (en) 2001-06-25
EE200000694A (en) 2002-06-17
SK17762000A3 (en) 2001-07-10
JP2002516874A (en) 2002-06-11
CN1299285A (en) 2001-06-13
EP1082132A1 (en) 2001-03-14
BR9815966A (en) 2001-02-28
NO20006022L (en) 2001-01-26
KR20010052454A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
DE69931507D1 (en) INTERFERON-BETA FUSION PROTEINS AND ITS USES
DK0960127T3 (en) Isolated dimeric fibroblast activating protein alpha and uses thereof
TR200001218T2 (en) Substituted carboxamidothiazoles, their manufacture and pharmaceutical compositions containing them.
PE20000560A1 (en) USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C
MXPA02006679A (en) Pharmaceutical composition.
EP0695171A1 (en) LONOSPHERES CONTAINING GONADOTROPHIN
ATE73321T1 (en) DELAYED DELIVERY COMPOSITION.
MY122262A (en) Lh-rh peptide analogues their uses and pharmaceutical compositions containing them
EA200501699A1 (en) STABILIZED INTERFERON LIQUID COMPOSITIONS, NOT CONTAINING HUMAN SERUM ALBUMIN
BR9811094A (en) Therapeutic agent for lymphatic tumors
TW200510528A (en) Polypeptide inducing apoptosis
IT1293778B1 (en) 1,4,7,10-TETRAAZABICICLO (8.2.2.)TETRADECAN-2 ONE, ITS PREPARATION AND USE FOR THE PREPARATION OF TETRAAZAMACROCYCLES
TR199902334T2 (en) New therapeutic combinations of mirtazapine and antipsychotic agents for the treatment or prophylaxis of psychotic disorders.
ES2117976T3 (en) PREPARATION OF N-ACETYL NEURAMINIC DERIVATIVES.
SE9702680D0 (en) New formulation
ES2084149T3 (en) CONJUGATES OF HIRUDINPOLIALQUILENGLICOL.
TR200003521T2 (en) Re-combined human interferon beta-1a (IFN-beta-1a) formulation.
TR200101493T2 (en) Eletriptan hydrobromide monohydrate
TR200001724T2 (en) 5-HT1F Agonists
DK0773782T3 (en) Terpene derivatives (sarcodictyins) use as antitumor agents
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
ES2142840T3 (en) PROTEIN THAT JOINS THE ALPHA / BETA INTERFERON, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
ATE57526T1 (en) P-ACYLAMINOBENZAMIDE.
TR199900748A2 (en) Using combination of osteinductive protein and dorsalizing factor.
FI970318A0 (en) Compounds useful as antiproliferative agents and Garft inhibitors